Disclosure Under Regulation 29(2) of SEBI(Substantial Aaquisition of Shares And Takeovers) Regulations, 2011 received from Jagdish Agrawal
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Drugs & Industries Ltd has informed the stock exchanges about receiving a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, from Jagdish Agrawal, who is part of the promoter group. Regulation 29(2) requires promoters and other significant shareholders to disclose changes in their shareholding, typically when acquisitions or disposals cross the 2% creeping acquisition limit in a financial year. The headline does not specify whether this is a purchase or a sale, nor the exact number of shares or percentage involved. Shareholders should look for the detailed disclosure on the BSE website for specifics on the transaction type, quantity, and revised shareholding.
This is a routine regulatory compliance filing rather than a major event on its own, but it signals a change in the promoter's stake that investors should monitor. Depending on whether it is a buy (positive/confidence signal) or a sale (potentially cautious signal), the stock may see modest sentiment impact once the full details are published.